2026-07-20T12:59:46Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1347962026-04-16T00:22:23Zcom_20.500.14352_14col_20.500.14352_15

00925njm 22002777a 4500 dc Rodríguez Portal, José Antonio author Brito García, Noé author Díaz Del Campo Fontecha, Petra author Valenzuela, Claudia author Ortiz, Ana María author Nieto Barbero, María Asunción author Mena-Vázquez, Natalia author Cano-Jiménez, Esteban author Castellví, Iván author Aburto, Myriam author Bonilla, Gema author Hernández Hernández, María Vanesa author Francisco Hernández, Félix Manuel author Correyero Plaza, María author Castrejón Fernández, Isabel author Narváez, Javier author Abad Hernández, Miguel Ángel author 2022-10 OBJECTIVE: To develop multidisciplinary recommendations to improve the management of rheumatoid arthritis-related interstitial lung disease (RA-ILD). METHODS: Clinical research questions relevant to the objective of the document were identified by a panel of rheumatologists and pneumologists selected based on their experience in the field. Systematic reviews of the available evidence were conducted, and evidence was graded according to the Scottish Intercollegiate Guidelines Network (SIGN) criteria. Specific recommendations were made. RESULTS: Six PICO questions were selected, three of which analysed the incidence and prevalence of RA-ILD, associated risk factors, and predictors of progression and mortality. A total of 6 specific recommendations on these topics, structured by question, were formulated based on the evidence found and/or expert consensus. CONCLUSIONS: We present the first official SER-SEPAR document with specific recommendations for RA-ILD management developed to resolve some common clinical questions and facilitate decision-making for patients. Rodríguez Portal JA, Brito García N, Díaz Del Campo Fontecha P, Valenzuela C, Ortiz AM, Nieto MA, et al. Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 1: epidemiología, factores de riesgo y pronóstico. Reumatología Clínica 2022;18:443–52. https://doi.org/10.1016/j.reuma.2022.02.009 10.1016/J.REUMA.2022.02.009 https://hdl.handle.net/20.500.14352/134796 https://doi.org/10.1016/J.REUMA.2022.02.009 36085196 https://www.reumatologiaclinica.org/en-ser-separ-recommendations-for-management-rheumatoid-articulo-S2173574322001265 SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis.